Clyde Biosciences
PrivateLast Round
Series A
Apr 15, 2015
Total Funding Raised
$3.11M
Company Overview
Clyde Biosciences operates in Healthcare & Life Sciences and is based in the United Kingdom. Its latest recorded funding round was a Series A round in April 2015.
Clyde Biosciences is a contract research organization that provides cardiac safety testing services to pharmaceutical and biotech companies using its proprietary cardiomyocyte assay platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clyde Biosciences Comparables
Compare Clyde Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metrion Biosciences | 86% | |
| AnaBios | 82% | |
| Ncardia | 82% |
For institutional investors. Book with your work email.
Clyde Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 15, 2015 | ||||
| Grant | Sep 13, 2013 | ||||
| Seed | Mar 1, 2012 |
For institutional investors. Book with your work email.
Clyde Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Seed |
| Epidarex Capital | Series A |
| Innovate UK | Grant |
| Glasgow University Holdings Ltd | Series A |
| Scottish Investment Bank (Scottish Enterprise) | Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 155% MoM to 2.5K.
- Jan 21, 2026
Monthly visitors grew 218% MoM, from 366 to 1.2K.
For institutional investors. Book with your work email.
Clyde Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clyde Biosciences's valuation, stock price, and market status.
Is Clyde Biosciences a public or private company?
Clyde Biosciences is a private company.
What is the current stock price of Clyde Biosciences?
Clyde Biosciences is a private company, so its shares have no public market price. Caplight tracks Clyde Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clyde Biosciences worth (valuation)?
Valuation information for Clyde Biosciences is not publicly available.
Can I buy Clyde Biosciences stock?
Clyde Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clyde Biosciences's last funding round?
Clyde Biosciences's most recent funding round was Series A on April 15, 2015.
Who are the main investors in Clyde Biosciences?
Key investors in Clyde Biosciences include Epidarex Capital.
Will Clyde Biosciences IPO soon?
No public IPO plans have been announced for Clyde Biosciences.
How can I track Clyde Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Clyde Biosciences's shares on secondary markets.